prednisolone has been researched along with Borderline Lepromatous in 5 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chew, R | 1 |
| Woods, ML | 1 |
| Bathula, S | 1 |
| Sardana, K | 1 |
| Mathachan, SR | 1 |
| Khurana, A | 1 |
| Ahuja, A | 1 |
| Paliwal, P | 1 |
| Noda, M | 1 |
| Tsunemi, Y | 1 |
| Masui, Y | 1 |
| Yoshizaki, A | 1 |
| Ohmatsu, H | 1 |
| Takazawa, Y | 1 |
| Ishii, N | 1 |
| Hossain, D | 1 |
| Vinod, KV | 1 |
| Chandramohan, R | 1 |
| Dutta, TK | 1 |
| Rajesh, NG | 1 |
| Basu, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum (MaPS in ENL[NCT03775460] | 550 participants (Anticipated) | Interventional | 2023-01-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for prednisolone and Borderline Lepromatous
| Article | Year |
|---|---|
Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
Topics: Adult; Clofazimine; Drug Therapy, Combination; Erythema Nodosum; Female; Humans; Leprostatic Agents; | 2013 |
4 other studies available for prednisolone and Borderline Lepromatous
| Article | Year |
|---|---|
Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Topics: Abattoirs; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Dapsone; Diagnosis, Differe | 2021 |
A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
Topics: Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leprosy, Multibacillary; Pannicu | 2023 |
Leprosy with spontaneous type 1 lepra reaction as an initial cutaneous manifestation: a case from Japan.
Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Edema; Erythema; Female; Humans; Leprosta | 2018 |
Type 2 lepra reaction as a cause of pyrexia of unknown origin.
Topics: Anti-Inflammatory Agents; Arthralgia; Fever; Humans; Leprostatic Agents; Leprosy, Multibacillary; Ma | 2012 |